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  Blood-borne angiotensin-II (Ang-II) has profound effects 
in  the  brain.  We  tested  the  hypothesis  that  Ang-II- 
dependent hypertension involves differential Ang-II type I 
(AT1) receptors expression in the subfornical organ (SFO) 
and  the  rostral  ventrolateral  medulla  (RVLM).  Male 
Wistar  rats  were  implanted  with  14-day  osmotic 
minipump  filled  with  Ang-II  (150  ng/kg/min)  or  saline. 
AT1 receptor mRNA levels were detected in the SFO and 
RVLM  by  reverse  transcription-polymerase  chain 
reaction (RT-PCR). Ang-II caused hypertension (134 ±  10 
mmHg  vs.  98  ±  9  mmHg,  n  =  9,  p  <  0.05).  RT-PCR 
revealed  that  Ang-II  infusion  induced  increased  AT1 
receptor mRNA levels in RVLM and decreased in SFO. 
Our  data  suggest  that  Ang-II-induced  hypertension 
involves differential expression of brain AT1 receptors.
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Blood-borne angiotensin-II (Ang-II) has profound effects 
on the central nervous system, including promotion of 
thirst, regulation of vasopressin secretion, and modulation 
of sympathetic outflow. In addition to blood-borne Ang-II, 
all components of the renin-angiotensin system are 
localized in the brain [11]. Within the brain, the renin- 
angiotensin system plays an important role in blood 
pressure regulation through its ability to modulate 
sympathetic nerve activity, especially in areas of the brain 
involved in the generation and modulation of the 
sympathetic discharge to cardiovascular system. Among 
those, two major areas are responsible for the sympath-
oexcitatory actions of Ang-II: the subfornical organ (SFO) 
and the rostral ventrolateral medulla (RVLM) [7,13]. 
The SFO is one of the circumventricular organs that lie 
outside the blood-brain-barrier and, thus, have access to 
circulating and intraventricular Ang-II. Moreover, angio-
tensinergic connections between the SFO and hypothalamic 
nuclei control drinking and modulate sympathetic nerve 
activity [6]. In addition to the SFO, the RVLM contains 
bulbospinal neurons that mediate a number of sympathe-
tically mediated reflexes and contribute to some disease 
states caused by sympathoexcitation, such as hypertension 
[7]. Of note, a high density Ang-II type 1 (AT1) receptor is 
found in the RVLM [2] and microinjection of Ang-II into the 
RVLM produces an AT1 receptor-mediated enhancement in 
sympathetic activity resulting in increases in blood pressure 
[3,5]. Furthermore, the overexpression of AT1 receptors in 
the RVLM increases blood pressure [1], and the blockade 
of RVLM AT1 receptors reduces blood pressure in several 
forms of experimental hypertension [8,9,12]. 
Although various forms of hypertension are characterized 
by an elevation in Ang-II levels in the periphery, resulting in 
sympathetic overactivity, the signaling mechanism by which 
Ang-II reaches brain areas involved in blood pressure control 
to modulate the sympathetic nerve activity is largely 
unknown. In the present study we tested the hypothesis that 
increased circulating Ang-II levels activate AT1 receptors 
in the SFO, which in turn induce local production of Ang-II 
within the brain, increasing the Ang-II signaling in the 
rostral ventrolateral medulla by overexpression of AT1 
receptors.
Adult male Wistar rats (250∼280 g) were housed in a 
temperature-controlled room set to alternating 12-hour 
light-dark cycle with free access to standard rat chow 
(Labina; Purina, Brazil). All procedures were approved by 
the Federal University of Paraiba Animal Care and Use 
Committee, Brazil.
Rats were subcutaneously implanted with 14-day osmotic 
minipumps (Alzet; Durect Corporation, USA) filled with 
Ang-II (150 ng/kg/min) or saline. Therefore, animals were 
divided in two experimental groups: rats that were treated 
with saline (saline group, n = 25) and rats that were treated 
with Ang-II (Ang-II group, n = 28). After the drug infusion 292    Valdir A. Braga
Fig. 1. Real time-PCR analysis at 14 days of angiotensin-II 
(Ang-II) infusion reveals down-regulation of Ang-II type I 
receptors (AT1 R) in the subfornical organ (A and B) and 
up-regulation of AT1 R in the rostral ventrolateral medulla (C and
D). *p < 0.05, when compared to saline group (n = 3, biological
samples; 5 rat per sample).
period, rats were anesthetized with ketamine and xylazine 
(75 and 10 mg/kg, intra-peritoneally, respectively) and 
fitted with a femoral arterial catheter for arterial pressure 
recordings, as described previously [3]. Briefly, blood 
pressure measurements were performed ≥ 24 h after 
catheter implantation. On the day of the experiment, the 
mean arterial pressure was recorded for 1 h in conscious 
rats using the software DataTrax 2 (LabTrax 2-24T; World 
Precision Instruments, USA). 
In a subset of animals, rats were decapitated and brains 
were flash-frozen. Total RNA was extracted from fresh 
SFO and RVLM punches (five rats per biological sample 
from each group, run in triplicate) using TRIzol Reagent 
(Life Technologies, USA) according to the manufacturer’s 
protocols. The cDNA species were synthesized using 
SuperScript II (Life Technologies, USA) from 1 μg of total 
RNA in a total volume of 20 μL with a random primer in 
accordance with the manufacturer’s instructions. Real time 
PCR for AT1 receptors and β-actin (internal control) was 
performed as follows: the total volume was 25 μL, which 
was comprised of 1× SYBR PCR master mix, 300 nM of 
forward primer (5´-TAACATGAGCTCAGCCGCCAA-
A-3´), 300 nM of reverse primer (5´-TCGTGAGCC-
ATTTAGTCCGATGCT-3´) and 25 ng of cDNA. The PCR 
reaction was carried out in triplicate using an ABI 7500 
Fast Real-Time PCR System (Applied Biosystems, USA) 
with the following thermal cycle parameters: 2 min at 50
oC, 
10 min at 95
oC, 40 cycles of 15 sec each at 95
oC and 1 min 
at 60
oC. The data were analyzed with Sequence Detection 
Software v1.4 (Applied Biosystems, USA). The ΔCt relative 
expression approach (relative expression = 2
−ΔCt, where Δ
Ct = Ct(target gene)−Ct(control gene)) was employed to examine 
mRNA expression of AT1a receptors relative to β-actin.
Results are expressed as mean ± SE and were analyzed by 
the Student’s t test. All statistical analyses were performed 
using GraphPad Prism (v. 5.0; GraphPad Software, USA). 
Statistical significance was defined as p < 0.05.
Rats treated with Ang-II presented a significant increase 
in blood pressure after 14 days of Ang-II infusion com-
pared to rats infused with saline (134 ± 10 mmHg vs. 98 ± 
9 mmHg, n = 13,  p < 0.05). Changes in AT1 receptor 
mRNA levels in the SFO and in the RVLM (SFO being an 
important cardiovascular regulatory region that potentially 
influences Ang-II signaling events at the RVLM) caused 
by two weeks of peripheral infusion of Ang-II are 
presented in Fig. 1. AT1 receptor mRNA levels in the 
RVLM were significantly increased by approximately 
240% at day 14 of the Ang-II infusion compared to the 
saline control group (fold change = 3.40 ± 0.50, n = 15). In 
contrast, AT1 receptor mRNA levels were significantly 
decreased in the SFO (fold change = 0.40 ± 0.20, n = 15) 
compared to saline control.
Here we report that chronic angiotensin-II infusion 
evoked an increase in AT1 receptor mRNA levels in the 
RVLM and decrease in AT1 receptor mRNA levels in the 
SFO as determined by real-time PCR. One important 
limitation of the present study is that we investigated the 
AT1 receptors expression only at the mRNA level. The 
confirmation of the AT1 receptors expression at the protein 
level by Western blot would be appropriate.
The important role of the SFO, a circunventricular organ 
involved in integrating signals from circulating angiotensin-II 
as well as local de novo production of this peptide, has been 
recognized [2,14]. In the present investigation, we also 
focused our attention on the RVLM because this brain 
region is the final relay point of the SFO-PVN-RVLM axis 
before transmission of signals generated by the brain 
renin-angiotensin system to the periphery [4]. Moreover, 
the RVLM controls sympathetic outflow and expresses 
renin and angiotensinogen locally [5,10].
Chronic Ang-II infusion also resulted in an increase in 
AT1 receptor mRNA levels in the RVLM as determined by 
quantitative real-time PCR, which may serve as evidence 
that enhanced Ang-II signaling within the RVLM results in 
hypertension. Increasing the expression of the AT1 rece-
ptors (up-regulation) in the RVLM would make the system Brain AT1 receptor expression during hypertension    293
more responsive to Ang-II released from angiotensinergic 
neurons, therefore increasing the firing rate of sympathetic 
neurons within the RVLM. Interestingly, AT1 receptor 
mRNA levels were decreased in the SFO of Ang-II infused 
rats. This phenomenon could be explained by the fact that 
increased circulating levels of Ang-II would reduce the 
expression of AT1 receptors (down-regulation) in that 
region, which is in intimate contact with the plasma 
Ang-II.
Here, using combined in vivo and molecular biology 
approaches, we report that the infusion of Ang-II induces 
differential AT1 receptor expression in two important areas 
of the brain involved in blood pressure and sympathetic 
activity regulation. The mechanism by which circulating 
Ang-II translates in sympathetic-mediated hypertension 
might involve changes in AT1 receptor expression in the 
RVLM and in the SFO. 
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